TFC Therapeutics is developing novel biologics to target and eliminate key drivers of cancer recurrence and metastasis. We’re blending early-stage research with innovative platform design to develop next-generation treatments to eliminate the most resilient cancers and put an end to their recurrence before it begins.
Company Details
- Employees
- 5
- Founded
- 2023
- Address
- 3960 Broadway,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.tfctx.com
- HQ
- New York, NY
Tfc Therapeutics Questions
Tfc Therapeutics's website is http://www.tfctx.com
Tfc Therapeutics's LinkedIn profile is https://www.linkedin.com/company/tfc-therapeutics
Tfc Therapeutics has
5 employees.
View email and phone details for 5
employees at Tfc Therapeutics.
Tfc Therapeutics's industry is
Biotechnology Research
Tfc Therapeutics's top competitors are
Bicara Therapeutics,
Antiva Biosciences, Inc.,
Endotope Biosciences,
Immunitas Therapeutics,
Epitor Therapeutics,
Stelexis Biosciences, Inc.,
Vertex Pharmaceuticals,
Volastra Therapeutics,
Nanotherix,
Cashback.io.
Tfc Therapeutics's categories are Biotechnology Research
Tfc Therapeutics's founding year is 2023
